2AL-20361-43931
1 vaccination
3 coded responses
8 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 982 / WA
- Registered
- 2021-01-11
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-01-10
Dose 1 — Moderna
-
2021-01-11
Registered in v-safe
-
2021-01-11
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body achesAdult check-in
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-14
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Itching · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-01-27
- 2021-02-02
-
2021-02-14
Survey response — day 35, dose 1MedDRA: Fatigue, Headache, Oropharyngeal pain — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Sore throat, headache, fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-12
Survey response — 3 months, dose 1MedDRA: Dizziness — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2022-01-10
Survey response — 12 months, dose 1MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-01-10
Report sent to call center — 12 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
- 2022-01-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-10 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-14 | priority 2/3 | |
| 2022-01-10 | Unsuccessful |
Free text
Release 4 — day 35, dose 1
Symptoms: Sore throat, headache, fatigue
Release 7 — 3 months, dose 1
Symptoms: Dizziness
Release 10 — 12 months, dose 1
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release